These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8401376)

  • 1. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.
    Gestin JF; Faivre-Chauvet A; Mease RC; Sai-Maurel C; Thédrez P; Slinkin M; Meinken GE; Srivastava SC; Chatal JF
    Nucl Med Biol; 1993 Aug; 20(6):755-62. PubMed ID: 8401376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--II. Comparative pharmacokinetics and biodistribution in human colorectal carcinoma-bearing nude mice.
    Faivre-Chauvet A; Gestin JF; Mease RC; Sai-Maurel C; Thédrez P; Slinkin M; Meinken GE; Srivastava SC; Chatal JF
    Nucl Med Biol; 1993 Aug; 20(6):763-71. PubMed ID: 8401377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
    Slinkin MA; Curtet C; Faivre-Chauvet A; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
    Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
    Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
    Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
    Govindan SV; Goldenberg DM; Griffiths GL; Leung SO; Losman MJ; Hansen HJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5721s-5725s. PubMed ID: 7493334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bifunctional antibody: a binary radiopharmaceutical delivery system for imaging colorectal carcinoma.
    Stickney DR; Anderson LD; Slater JB; Ahlem CN; Kirk GA; Schweighardt SA; Frincke JM
    Cancer Res; 1991 Dec; 51(24):6650-5. PubMed ID: 1742739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
    Lewis MR; Shively JE
    Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A convenient and flexible approach for introducing linkers on bifunctional chelating agents.
    Studer M; Meares CF
    Bioconjug Chem; 1992; 3(5):420-3. PubMed ID: 1420441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
    Sun B
    Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimized antibody-chelator conjugate for imaging of carcinoembryonic antigen with indium-111.
    Sumerdon GA; Rogers PE; Lombardo CM; Schnobrich KE; Melvin SL; Hobart ED; Tribby II; Stroupe SD; Johnson DK
    Int J Rad Appl Instrum B; 1990; 17(2):247-54. PubMed ID: 2341278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new radioligand for the epidermal growth factor receptor: 111In labeled human epidermal growth factor derivatized with a bifunctional metal-chelating peptide.
    Rémy S; Reilly RM; Sheldon K; Gariépy J
    Bioconjug Chem; 1995; 6(6):683-90. PubMed ID: 8608180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.
    Gridley DS; Ewart KL; Cao JD; Stickney DR
    Cancer Res; 1991 Mar; 51(5):1515-20. PubMed ID: 1997192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a chimeric bifunctional antibody specific for human carcinoembryonic antigen and indium-benzyl-EDTA.
    Beidler DE; Johnson MJ; Unger BW; Phelps JL; Jue RA
    Protein Expr Purif; 1991 Feb; 2(1):75-82. PubMed ID: 1821776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of metabolites of 111In-diethylenetriaminepentaacetic acid-monoclonal antibodies and antibody fragments in vivo.
    Rogers BE; Franano FN; Duncan JR; Edwards WB; Anderson CJ; Connett JM; Welch MJ
    Cancer Res; 1995 Dec; 55(23 Suppl):5714s-5720s. PubMed ID: 7493333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
    Meares CF; McCall MJ; Reardan DT; Goodwin DA; Diamanti CI; McTigue M
    Anal Biochem; 1984 Oct; 142(1):68-78. PubMed ID: 6440451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of DTPA to antibody ratio on chemical, immunological and biological properties of the 111In-labelled F(ab')2 fragment of the monoclonal antibody 431/31.
    Kuhlmann L; Steinsträsser A
    Int J Rad Appl Instrum B; 1988; 15(6):617-27. PubMed ID: 3251897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients.
    Hnatowich DJ; Mardirossian G; Rusckowski M; Roy S; Bushe H; Griffin TW; Brill AB
    Nucl Med Commun; 1993 Jan; 14(1):52-63. PubMed ID: 8423936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.